{"id":"W3020554662","doi":"10.14740/jh596","title":"Prolonged Remission by Pembrolizumab and Brentuximab-Vedotin Combination Therapy in Heavily-Pretreated Relapsed/Refractory Hodgkin’s Lymphoma","year":2020,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Brentuximab vedotin; Pembrolizumab; Medicine; Oncology; Internal medicine; Refractory (planetary science); Lymphoma; Chemotherapy; Immunotherapy; Hodgkin lymphoma; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001702869,0.0001827426,0.0006897659,0.0001506703,0.00004227304,0.0000142799,0.00007713518,0.0001838214,0.00005751515],"category_scores_gemma":[0.0001784512,0.0001311512,0.0000980334,0.0001683604,0.00005886173,0.0001153355,0.00002611732,0.0001730149,0.000006420329],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000183122,"about_ca_system_score_gemma":0.0001705762,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002456051,"about_ca_topic_score_gemma":0.000002839243,"domain_scores_codex":[0.9985754,0.0001567494,0.0006035775,0.0002105704,0.0002442322,0.0002094639],"domain_scores_gemma":[0.9989626,0.000137778,0.0004122503,0.000121471,0.0001295363,0.0002364066],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009046083,0.005403289,0.8670419,0.0001844217,0.0003622429,0.002739354,0.001840242,0.000001261272,0.01921288,0.0003701405,0.02037858,0.07341954],"study_design_scores_gemma":[0.1319854,0.01944648,0.7305902,0.0008696796,0.0002841793,0.01304731,0.0004076379,0.0006347199,0.08654112,0.000541241,0.01521233,0.0004396868],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9789835,0.008352062,0.000009734025,0.0120105,0.0001001254,0.0002869079,0.000002870168,0.00001813116,0.0002361841],"genre_scores_gemma":[0.9965825,0.002218173,0.0001481722,0.0009388988,0.00003883851,0.000009808643,0.00001348373,0.000019991,0.00003014663],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1364517,"threshold_uncertainty_score":0.534819,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01688004400717126,"score_gpt":0.2655876156758354,"score_spread":0.2487075716686642,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}